Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Oligodendroglioma × Lomustine × Clear all

Phase

Phase 3 4 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Recurrence 2 Astrocytoma 2 Oligodendroglioma 1 Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Radiotherapy 2 vocimagene amiretrorepvec 1 Vincristine 1 Temozolomide 1 Radiation 1 Procarbazine 1 Lomustine 1 DNA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003375 2024-07-09

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Radiation Therapy Oncology Group

Phase 2/3 Completed

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡